GlassScriptPhysician profile
Alan P Krieger
NPI 1740385772
$3,249.42
in general payments reported to CMS, 2019-2025
33 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2020: $339 · 2021: $766 · 2022: $151 · 2023: $244 · 2024: $120 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $748.85 | 2019-2021 | |
| Urogen Pharma, INC. | $238.69 | 2021-2023 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $194.30 | 2019-2025 | |
| Pfizer INC. | $179.33 | 2019-2020 | |
| Abbvie INC. | $172.93 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $147.31 | 2019-2022 | |
| Axonics, INC. | $129.59 | 2023 | Axonics, Bulkamid |
| Ferring Pharmaceuticals INC. | $128.94 | 2019-2024 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $124.98 | 2025 | |
| Blue Earth Diagnostics | $123.59 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $121.84 | 2025 | |
| Procept Biorobotics Corporation | $115.23 | 2019-2020 | |
| Teleflex LLC | $113.66 | 2021-2022 | |
| Srs Medical Systems, INC. | $103.68 | 2019 | |
| Neotract INC. | $86.52 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $66.42 | 2019-2021 | |
| 180 Medical, INC. | $49.25 | 2020-2021 | |
| Janssen Biotech, INC. | $44.84 | 2019-2021 | |
| Amgen INC. | $43.35 | 2019-2020 | |
| Allergan, INC. | $40.28 | 2019 | |
| Dendreon Pharmaceuticals LLC | $37.21 | 2019 | |
| Medtronic USA, INC. | $32.52 | 2019 | |
| Emd Serono, INC. | $28.96 | 2019 | |
| Aytu Biopharma, INC. | $28.27 | 2019 | |
| Olympus America INC. | $22.12 | 2021 | |
| Ethicon US, LLC | $19.20 | 2019 | |
| Hollister Incorporated | $18.94 | 2020 | |
| Rochester Medical Corporation | $17.22 | 2021 | |
| Metuchen Pharmaceuticals | $15.04 | 2019 | |
| Merck Sharp & Dohme LLC | $14.92 | 2021 | |
| Clarus Therapeutics INC. | $14.69 | 2021 | |
| Urovant Sciences INC | $14.47 | 2021 | |
| Dentsply Ih INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Krieger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.